Categories
- Aesthetic Medicine
- Aesthetic Surgery
- Ai
- ALS Treatment
- Anatomy
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Batten Disease Treatment
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Bitcoin
- Brain Injury Treatment
- Cardiac Nursing
- Cardiac Regeneration
- Cardiac Remodeling
- Cardiac Rhythm Abnormalities
- Cardiac Surgery
- Cardiology
- Cardiomyopathies
- Cardiovascular Pharmacology
- Cell Medicine
- Cell Therapy
- Cerebral Palsy
- Cerebral Palsy Treatment
- Cheap Pharmacy
- Chemistry
- Clinical Cardiology
- Coronary Heart Diseases
- Cryptocurrency
- DNA
- Drug Dependency
- Drug Side Effects
- Drugs
- Eczema
- Elon Musk
- Embryology
- Erectile Dysfunction
- FDA Stem Cell Trials
- Femtomedicine
- Future Medicine
- Gene Medicine
- Gene Therapy
- Gene Therapy Trials
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Heart Diseases
- HGH
- Hgh Injections
- Hormone Replacement Therapy
- Human Genetics
- Human Growth Hormone
- Human Immortality
- Hyperbaric Medicine
- Hypertension
- Hypothalamus
- Impotency
- Internet Pharmacy
- Interventional Cardiology
- IVF Treatment
- Lyme Disease
- Male Sexual Dysfunction
- Mars Colony
- Medical Business
- Medical School
- Medical Technology
- Medicine
- Mental Health
- Mesenchymal Stem Cells
- Micropenia
- Molecular Cardiology
- MS Treatment
- Muscular Dystrophy Treatment
- Myocardial Infarction
- Nanotechnology
- Online Pharmacy
- Oral Health
- Parkinson's Treatment
- Pediatric Cardiology
- Penis Enlargement
- Pet Stem Cell Therapy
- Pharmacy
- Picomedicine
- Premature Ejaculation
- Prescriptions
- Retinitis Pigmentosa
- Sermorelin
- Singularity
- Sleep
- Spacex
- Spinal Cord Injury Treatment
- Stem Cell Clinical Trials
- Stem Cell Experiments
- Stem Cell Human Trials
- Stem Cell Injections
- Stem Cell Research
- Stem Cell Transplant
- Stem Cell Treatments
- Testosterone
- Ulcerative Colitis
- Uncategorized
- Vascular Biology
- Ventricular Remodeling
- Wholesale Pharmacy
Archives
Monthly Archives: July 2012
Caught in Honduras drugs crossfire
Posted: Published on July 16th, 2012
Please turn on JavaScript. Media requires JavaScript to play. Stephen Sackur joins a navy patrol crew in Honduras trying to stop the smuggling of cocaine to the United States. Honduras is in the grip of a drugs war with US drug enforcement agents helping local forces fight organised gangs, who traffic tons of cocaine destined for the United States, as HARDtalk's Stephen Sackur reports. The deep bullet wound in Hilda Lezama's thigh is a livid pointer to Honduras's unwanted status as a new frontline in America's war on drugs. For all of her 53 years, Hilda Lezama has lived in Ahuas, a settlement of wooden homes built on stilts, close to the fast-flowing Patuca river in the remote Mosquitia region of eastern Honduras. She was shot in a US-led counter-narcotics raid on a riverboat two months ago. Four other local people, including two local women, were killed in the airborne attack which involved US drug enforcement agents and Honduran troops. "We were returning from a trip down-river with the fishermen," Hilda recalled. "We travelled at night to avoid the heat. We heard the helicopters above us, but we couldn't see them. "They could have let us dock and then searched … Continue reading
Posted in Drugs
Comments Off on Caught in Honduras drugs crossfire
Research and Markets: 2012 Outsourcing Guide for the Drugs & Biotechnology Industry
Posted: Published on July 16th, 2012
DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/mj7whg/2012_outsourcing_g) has announced the addition of the "2012 Outsourcing Guide for the Drugs & Biotechnology Industry" report to their offering. The Drugs & Biotechnology industry profile includes four components: 1) Market Situation 2) Outsourcing Trends 3) ISG Observations 4) Several pages of outsourcing data. The data, graphics and analysis provide insight into outsourcing activity within the Drugs & Biotechnology vertical and subvertical levels, including 'Biotechs' and 'Pharmaceuticals'. This report from the ISG Momentum Market Trends & Insights series can help service providers develop an effective go-to-market strategy characterized by better targeting of opportunities and higher win and retention rates. The charts and graphics answer questions about market size and direction, as well as buying and spending patterns, allowing service providers to enhance account planning activity. All of the data in this report is based on the proprietary ISG Pervasiveness Research and ISG Databases, which are used to create the ISG Index and ISG Index Insider, among other publications. ISG is the founder of the sourcing advisory industry and the leading independent sourcing data and advisory firm in the world. The company's world-class global advisory staff works hand- in-hand with clients as they develop their outsourcing … Continue reading
Posted in Drugs
Comments Off on Research and Markets: 2012 Outsourcing Guide for the Drugs & Biotechnology Industry
Sex, Drugs, and Paper Towels
Posted: Published on July 16th, 2012
By Liz Hoffmann - July 16, 2012 | Tickers: CVS, ESRX, WAG | 0 Comments Liz is a member of The Motley Fool Blog Network -- entries represent the personal opinions of our bloggers and are not formally edited. What do sex, drugs, and paper towels have in common? They all have devotees who shop at CVS Caremark (NYSE: CVS). Whether it's young men and women for birth control, the sick and elderly for prescription drugs, or growing families for baby supplies and paper towels, you'll find them all at a CVS. And that's just the tip of the iceberg when it comes to the number of products distributed and demographic groups served. Now for some specifics: CVS has been on a respectable growth trajectory for the past 5 years, with revenues for that period increasing 19.57% and EPS growing at 10.11%. Dividends are paid quarterly and in 2012 have increased 30% versus the year ago perioddriving a 1.35% annualized dividend yield. And for the past 52 weeks, the stock has performed admirably logging a robust 27.44% increase in price. On Thursday, July 5th CVS reached its all-time high of $48.32 per share. It should be no surprise then that … Continue reading
Posted in Drugs
Comments Off on Sex, Drugs, and Paper Towels
Research and Markets: Medicinal Chemistry of Anticancer Drugs
Posted: Published on July 16th, 2012
DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/pd8hns/medicinal_chemistr) has announced the addition of Elsevier Science and Technology's new report "Medicinal Chemistry of Anticancer Drugs" to their offering. Antitumour chemotherapy is nowadays a very active field of research, and a huge amount of information on the topic is generated every year. Although many books are available that deal with clinical aspects of cancer chemotherapy, this book addresses the need for an updated treatment from the point of view of medicinal chemistry and drug design. Cytotoxic chemotherapy is gradually being supplemented by a new generation of drugs that recognize specific targets on the surface or inside cancer cells. These therapies are in their infancy, but they hold promise of more effective therapies with fewer side effects. Resistance to antitumour drugs is another important but normally neglected field. The focus of Medicinal Chemistry of Anticancer Drugs is on the mechanism of action of antitumour drugs from the molecular point of view and on the relationship between chemical structure and chemical and biochemical reactivity of antitumour agents, aiming at the rationalization of the action of this type of drugs, which would allow the design of new active structures. - Presents information in a clear and concise … Continue reading
Posted in Drugs
Comments Off on Research and Markets: Medicinal Chemistry of Anticancer Drugs
Allen defends C4 Drugs Live show
Posted: Published on July 16th, 2012
16 July 2012 Last updated at 09:36 ET Keith Allen has defended a forthcoming Channel 4 series in which he is filmed taking drugs. The musician and actor took MDMA, the pure form of ecstasy, for the upcoming documentary to examine its effects. Health campaigners said the show ran the risk of being "voyeuristic" and "unrepresentative". But the 59-year-old actor and musician said the documentary was designed as a "forensic analysis" into the physical and psychological effects of drugs. Called Drugs Live, the "radical" four-part series aims to examine the claims and counterclaims made about recreational drugs by testing them in a monitored environment. TV bosses at Channel 4 said the series, to be broadcast in the autumn, would "provide viewers with unmediated access to a live drug trial". Speaking on ITV 1's This Morning, Allen said it was "insane" to suggest the show glamorised drug use. "If you think that I'm glamorising the taking of drugs by spending an hour and 20 minutes for two consecutive Mondays in an MRI scanning machine, then you're insane. We wouldn't want anyone to come away from the programme thinking that MDMA is benign. Read more here: Allen defends C4 Drugs Live show … Continue reading
Posted in Drugs
Comments Off on Allen defends C4 Drugs Live show
(Metro News) UMAK opens center of Pharmacy
Posted: Published on July 16th, 2012
MANILA The city government-owned University of Makati has opened its Center of Pharmacy, the first of its kind in the country, under the College of Allied Health Studies (COAHS) for this school year 2012-2013. In a report to Makati Mayor Jejomar Erwin S. Binay, university president Tomas Lopez said the Center of Pharmacy offers a six-year ladderized program consisting of the following two-year courses: Associate of Applied Science in Pharmaceutical Technology; Bachelor of Science in Pharmacy with added specialization in Pharmaceutical Marketing, and Doctor of Pharmacy. Lopez said under the program, graduates of the first two-year course, Associate of Applied Science in Pharmaceutical Technology, could already work competently as skilled pharmacy technicians and pharmacy assistants under the supervision of a licensed pharmacist in settings such as a community pharmacy, hospital pharmacy or a healthcare institution. He or she may also work independently as research assistant, and also in pharmaceutical, cosmetic or medical equipment dealerships. Graduates of the said course have the option to pursue a degree in Bachelor of Science in Pharmacy, which offers added specialization in Pharmaceutical Marketing. Those who want to be a licensed pharmacist can continue for two more years to complete the professional program. UMAK is … Continue reading
Posted in Pharmacy
Comments Off on (Metro News) UMAK opens center of Pharmacy
UCB Launches Neupro® in the U.S. to Treat Parkinson’s Disease and Restless Legs Syndrome
Posted: Published on July 16th, 2012
BRUSSELS & ATLANTA--(BUSINESS WIRE)-- UCB announced today that Neupro (Rotigotine Transdermal System) is now available in U.S. pharmacies. Neupro was approved by the U.S. Food and Drug Administration in April to treat the signs and symptoms of early and advanced stage idiopathic Parkinsons disease and moderate-to-severe primary Restless Legs Syndrome. Neupro improves motor function and activities of daily living in patients with PD and provides effective symptom relief for patients with Restless Legs Syndrome (RLS). Neupro is a once-daily patch that provides continuous delivery of the dopamine agonist rotigotine for 24 hours. Over 100,000 patients have been treated with Neupro worldwide, and seven clinical trials for the approved indications have demonstrated efficacy, safety and tolerability. The availability of Neupro is an important step forward for U.S. patients living with Parkinsons disease and Restless Legs Syndrome, said Roch Doliveux, Chief Executive Officer, UCB. "UCB is dedicated to delivering innovative medicines like the Neupro transdermal patch to people living with serious illnesses such as Parkinsons disease and Restless Legs Syndrome, by combining the latest science and technology with our researchers' insights on the holistic needs of patients. One million Americans are currently living with PD. The cardinal motor symptoms of PD include … Continue reading
Posted in Parkinson's Treatment
Comments Off on UCB Launches Neupro® in the U.S. to Treat Parkinson’s Disease and Restless Legs Syndrome
Addex Announces the Publication of Positive Data on the Efficacy of mGluR4 Positive Allosteric Modulator in Parkinson …
Posted: Published on July 16th, 2012
PLAN-LES-OUATES GENEVA, SWITZERLAND--(Marketwire -07/16/12)- Addex Therapeutics / Addex Announces the Publication of Positive Data on the Efficacy of mGluR4 Positive Allosteric Modulator in Parkinson's Disease Pre-Clinical Models . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. Seminal Research Provides Greater Insight into the Role of Selective mGluR4 Modulation on Motor Symptoms in Parkinson's disease Geneva, Switzerland, 16 July 2012 - Addex Therapeutics (SIX:ADXN), a leading company pioneering allosteric modulation-based oral small molecule drug discovery and development, announced today the publication of positive pre- clinical efficacy data on its novel, highly selective oral small molecule positive allosteric modulator (PAM) of metabotropic glutamate receptor 4 (mGluR4), and its role in Parkinson's disease. The results were published in the Journal of Pharmacology and Experimental Therapeutics (JPET) on 11 July 2012 as DOI:10.1124/jpet.112.196063. The researchers report the discovery of ADX88178, a novel, potent, brain penetrant and selective mGluR4 PAM, with drug- like properties, to explore the therapeutic potential of mGluR4 modulation in disease models. The research was conducted in collaboration with Merck & Co. "There continues to be a significant need for new approaches to treat Parkinson's disease. Research shows that increasing mGluR4 activity … Continue reading
Posted in Parkinson's Treatment
Comments Off on Addex Announces the Publication of Positive Data on the Efficacy of mGluR4 Positive Allosteric Modulator in Parkinson …
Taxpayers sweat the cost of 'healing' trip
Posted: Published on July 16th, 2012
A supplied picture of a modern Cree sweat lodge. Source: Supplied TAXPAYERS will fork out almost $21,000 to send a north Queensland assault victim overseas for spiritual healing on an Indian reserve. "Indigenous Canadian" Ruth Schaefer will fly with her friend, Hope Vale Aboriginal elder Gordon Charlie, on the trip to Cree Nations Treatment Haven in Saskatchewan, Canada - with both airfares paid for by the Justice Department. A Queensland tribunal ordered the trip, finding it "reasonable", as the treatment was only available in Canada. It found Ms Schaefer needed an escort and at least two stopovers each way. Ms Schaefer, who has post-traumatic stress disorder after a violent assault in 2007, went to Cree Nations in 2005 for trauma treatment in a sweat lodge and "a linking back to spiritual ancestors". The Canadian woman, who lives in Mareeba in north Queensland, said she now needs to return to the centre for "spiritual healing". At a Queensland Civil and Administrative hearing last month, Mr Charlie, who has known Ms Schaefer for 20 years, told QCAT that the healing programs for indigenous people in Australia were ineffective. The Justice Department previously rejected Ms Schaefer's request for financial assistance for the trip, … Continue reading
Posted in MS Treatment
Comments Off on Taxpayers sweat the cost of 'healing' trip
Research improving lives for MS patients
Posted: Published on July 16th, 2012
Discovering new medicines is often the first thing that comes to mind when people think about clinical trials. But some of the most important research occurs in optimizing previously approved drugs. These follow-up studies are used to test the tolerability of drugs already approved, optimize patient safety and address patient acceptance. An example of this type of research is underway now at The Corvallis Clinic involving patients who have multiple sclerosis. MS is a disease affecting the central nervous system, brain and spinal cord, causing problems with muscle control and strength, vision, balance, feeling and thinking. The Clinics Research Center participated in a previous study to evaluate fingolimod, marketed as Gilenya, the first-ever pill for treating the most common form of the disease, relapsing remitting MS. With relapsing remitting MS, patients experience attacks or relapses of symptoms, which are followed by periods of partial or complete recovery. Prior to Gilenya, medication was only available by injection. Although most patients are able to give themselves shots at home, it was a pain and a literal discomfort. These shots were also leading to a compliance problem, with patients not wanting to take their medicine. In studies, patients taking Gilenya showed improved compliance. … Continue reading
Posted in MS Treatment
Comments Off on Research improving lives for MS patients